1. Home
  2. GROV vs SCYX Comparison

GROV vs SCYX Comparison

Compare GROV & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GROV
  • SCYX
  • Stock Information
  • Founded
  • GROV 2016
  • SCYX 1999
  • Country
  • GROV United States
  • SCYX United States
  • Employees
  • GROV N/A
  • SCYX N/A
  • Industry
  • GROV Package Goods/Cosmetics
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GROV Consumer Discretionary
  • SCYX Health Care
  • Exchange
  • GROV Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • GROV 44.3M
  • SCYX 36.8M
  • IPO Year
  • GROV N/A
  • SCYX 2014
  • Fundamental
  • Price
  • GROV $1.38
  • SCYX $0.88
  • Analyst Decision
  • GROV Hold
  • SCYX
  • Analyst Count
  • GROV 1
  • SCYX 0
  • Target Price
  • GROV $1.20
  • SCYX N/A
  • AVG Volume (30 Days)
  • GROV 118.5K
  • SCYX 204.8K
  • Earning Date
  • GROV 05-14-2025
  • SCYX 05-15-2025
  • Dividend Yield
  • GROV N/A
  • SCYX N/A
  • EPS Growth
  • GROV N/A
  • SCYX N/A
  • EPS
  • GROV N/A
  • SCYX N/A
  • Revenue
  • GROV $193,427,000.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • GROV N/A
  • SCYX $460.12
  • Revenue Next Year
  • GROV $6.19
  • SCYX $253.87
  • P/E Ratio
  • GROV N/A
  • SCYX N/A
  • Revenue Growth
  • GROV N/A
  • SCYX N/A
  • 52 Week Low
  • GROV $1.02
  • SCYX $0.72
  • 52 Week High
  • GROV $1.95
  • SCYX $2.60
  • Technical
  • Relative Strength Index (RSI)
  • GROV 62.62
  • SCYX 48.64
  • Support Level
  • GROV $1.07
  • SCYX $0.72
  • Resistance Level
  • GROV $1.43
  • SCYX $1.02
  • Average True Range (ATR)
  • GROV 0.11
  • SCYX 0.08
  • MACD
  • GROV 0.03
  • SCYX 0.00
  • Stochastic Oscillator
  • GROV 86.11
  • SCYX 51.70

About GROV Grove Collaborative Holdings Inc.

Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: